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Abstract. The microsphere formulations of Chit/TPP/Sm/Fe3O4/Rn were prepared by an ionic gelation technique, where 
Chit = chitosan, TPP = tripolyphosphate, Sm = samarium and Rn = ranitidine. Optimum of microsphere formulation 
exhibit magnetic and fluorescent properties with adsorption efficiency of ~92% was obtained for Chit/TPP/Sm/Fe3O4/Rn 
with ratio 400:500:50:1:20. Fluorescence intensity of microsphere formulations increased with the cumulative amount 
release of ranitidine, so that the changing of fluorescence intensity at wavelength of 590 nm referring to the Sm3+ ion 
could be used as indicator in DDS. With the demonstration of sustained release from microsphere formulation, it allows 
to investigate the applications to other drugs. 
INTRODUCTION 
The fluorescence and magnetic properties of drug carrier composite have been recently reviewed, generally 
described the biological and biomedicine aplication [1]. This multifunctional materials allow to find and treat 
disease in the human body [2]. The effective diagnostic ability of the composite may reduce side effect of the drug. 
Very few materials can meet for drug delivery system. In order to meet good properties as a drug delivery system 
(DDS), thus we need  to design a composite which is non-toxic and photostability with a good fluorescence 
labelling. Due to their unique flouresence properties, lanthanide is highly candidate for sensor or labelling to 
overcome the various problem that associated in the coventional imaging probe or drug delivery carrier [3]. 
Samarium is one of lanthanide metal ion that possess an orange emission with wavelength at  595 nm. Magnetic 
Fe3O4 nanoparticles is superparamagnetic properties. This is very interesting and attractive physicochemical 
properties and multifunctional surface. This is excellent potential for physiological applications such as targeted 
drug and gene delivery [4]. We proposed for the simultaneous magnetic Fe3O4 nanoparticles and fluorescence 
properties from lanthanide-drug encapsulation with chitosan would result in a controlled and targeted drug delivery 
system. This is a key role in advancing light-based drug delivery systems, allowing us to construct a new 
fluorescence and magnetic properties for various bioapplications. 
Here, we discuss the multifunctional microsphere formulation of fluorescent-magnetic properties for drug 
delivery system of Chit/TPP/Sm/Fe3O4/Rn where Chit = chitosan, TPP = tripolyphosphate, Sm = samarium and Rn 
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Chitosan medical grade powder with deacetylation degree of 90.77%, off white, viscosity of 18 cps, moisture 
content of 6.61%, ash content of 0.73%, protein content of 60.5%, pH 7–8 was purchased from PT Biotech Surindo 
(West Java, Indonesia). Sm(NO3)3.6H2O was purchased from Sigma Aldrich (Wisconsin, USA). FeCl2.4H2O, 
FeCl3.6H2O and acetic acid were purchased from Merck, while for sodium tripolyphosphate was obtained from 
Brataco. 
 
Synthesis of Magnetic Fe3O4 Nanoparticles 
To 0.12 M solution of FeCl2.4H2O (50 mL) and 50 mL of 0.24 M FeCl3.6H2O solution was stirred and heated at 
70°C for 15 min. Then, the mixture solution was poured slowly into 100 mL of 1M NH4OH solution and keep 
stirred for 30 min. The solution was filtered, then the precipitate was washed by using distilled water, after that then 
dried at 70°C for 3 h in conventional oven. 
 
Synthesis of Chitosan-Fe-Ranitidine-Sm 
Chitosan solution was prepared by dissolving chitosan in 50 mL of 2% acetic acid solution. Chitosan was varied 
from 0.5  to 2.5 g. The Sm-ranitidine solution was prepared by dissolving 100 mg of ranitidine in 10 mL of distilled 
water, followed by adding Sm(NO3)3.6H2O were stirred for 30 min. The amount of Sm(NO3)3.6H2O were varied 
from 50 to 450 mg. Matrices of Chitosan-Fe-Sm-Ranitidine was synthesized by adding a certain amount of Fe3O4 
magnetic nanoparticles and Sm-ranitidine solution into the chitosan solution. Magnetic nanoparticles Fe3O4 were 
varied from 5 to 45 mg. Then, the solution mixture was stirred for 5 min and then transferred to microwave for 10 
min.  Next, 100 mL of sodium tripolipospat were put into the beaker in microwave and then stirred for 15 min to 
form microsphere. After that, the mixture was filtered and dried at 70°C by using an oven for 3 h. The TPP solution 
concentration was varied from 1 to 5%. The microspheres obtained were dried and crushed with mortar to form the 
Chitosan-Fe-Sm-Ranitidine matrices. Chitosan-Fe-Sm-Ranitidine matrices were characterized for further 
applications. 
 
Drug Loading and Drug Release Studies 
Preparation of drug adsorption and release system were prepared in accordance with literature [5]. In drug 
loading, 50 mg matrices was dissolved in 25 ml of distilled water and then allowed to stand for 24 h. After 24 h, 
retentate and the filtrate was measured its absorbance by using UV-Vis spectrophotometry.  In drug release, 25 mg 
matrix of ranitidine-chitosan-Fe-Sm was dissolved in 10 mL of simulation fluids are then stored in an incubator at 
37°C. A sample (2 mL) from container was taken every for 1 h and was added 2 mL of simulation fluids into the 
new container. Sampling was carried out during for 24 h. For further measurement, the samples was diluted to 10 
mL and then absorbance was recorded by using UV-Vis and spectroflourormeter.  
 
Characterization 
Drug loading and drug release test were determined by using UV-Vis spectrophotometry. Absorbance peak of 
the ranitidine concentration as model drug in the Ranitidine-Chitosan-Fe-Sm matrices were determined by UV-Vis 
spectrophotometry. Emission properties of matrices were analyzed by spectroflourometry, Hitachi F-2700. The 
nanoparticles of Fe3O4 and their microsphere composites were characterized by XRD, and vibrating sample 
magnetometer (VSM). 
RESULTS AND DISCUSSION 
Multifunctional formulation of magnetic and fluorescence properties based on the chitosan-Fe3O4-samarium-
ranitidine for drug delivery systems (DDS) have been investigated. The microsphere formulations of 
Chit/TPP/Sm/Fe3O4/Rn were prepared by an ionic gelation technique with sodium tripolyphosphate as cross-linking 
agent, where Chit = chitosan, TPP = tripolyphosphate, Sm = samarium and Rn = ranitidine. Magnetic nanoparticles 
Fe3O4 were characterized by X-Ray diffraction and vibrating sample magnetometer (VSM). X-ray diffraction (XRD) 
patterns showed that the crystal sizes of Fe3O4 nanoparticles and its optimum microspheres formulation were 13.24 
and 80.59 nm, respectively (see Figs. 1 and 2). The diffraction peaks are suitable for the Miller indices of (220), 
(311), (400), (440), (511) and (440) at an angles of 2  of 30.51, 35.52, 43.14, 53.58, 58.02, and 62.38o, respectively, 
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which were a typical index of the material structure of cubic spinel Fe3O4. The average crystal sizes of magnetic 
Fe3O4 nanoparticles are 21.25, and 13.24 nm for ratios Fe(II):Fe(III) = 1:1 and Fe(II):Fe(III) = 1: 2, respectively.
FIGURE 1. (a) XRD characterization result of Fe3O4, (b) VSM characterization result of Fe3O4
The XRD spectra of Chit/TPP/Sm/Fe3O4/Rn matrix is shown in Fig. 2(a). The magnetic Fe3O4 nanoparticles was
bonded with Chit/TPP/Sm/Fe3O4/Rn matrices. The diffraction peak at 2 = 20o, which is the diffraction peaks of 
chitosan. The intensity produced by Chitosan-Fe-Sm-Ranitidine composite is lower than pure nanomagnetic 
nanoparticles Fe3O4, it indicates that Fe3O4 has bonded with chitosan thus lowering the intensity value of Fe3O4. The
average crystal size of Chit/TPP/Sm/Fe3O4/Rn matrices is 80.59 nm that was calculated by using Debye Scherer 
equation.
The microsphere formulation of Chit/TPP/Sm/Fe3O4/Rn has a maximum magnetization of 2.6 emu/g (see Figure
2(b)). The maximum magnetization Fe3O4 pure is 28.9 emu/g. Then Fe3O4 has weakened because chitosan binds to 
the matrix. From the characterization results shown that microsphere formulation can be used as conductive matrix 
for targeted drug carrier. The magnetic Fe3O4 nanoparticles serves as a sensor or tracer of the drugs in the body. 
FIGURE 2. Characterization of chitosan-Fe-Sm-Ranitidine for (a) XRD and (b) VSM
In this study, we found that the microsphere formulations was nearly spherical in shape and had a diameter of 20 
- 30 m with composition of Sm and Fe were about 2.34 and 4.46%, respectively. Magnetic measurement for Fe3O4
nanoparticles reached 28.9 emu/g indicated the characteristic of superparamagnetic while the magnetic properties of 
microsphere formulations of chit/TPP/Sm/Fe3O4/Rn was about 2.6 emu/g, which was decreased compared with the 
original one (28.9 emu/g).  
The efficiency adsorption of ranitidine on the various of magnetic Fe3O4 nanoparticles concentrations are almost 
the same values because of the chemical bonding structure of chitosan-Fe-Sm-ranitidine matrices, the ranitidine as a 
model drug does not bind to the Fe ions, thus there is no significant effects on the efficiency adsorption of ranitidine.
Therefore the magnetic Fe3O4 nanoparticles concentration of 100 ppm was selected as the optimum concentration in 
the formulation of chitosan-Fe-Sm-ranitidine matrices. Optimum of microsphere formulation with adsorption 
efficiency of 92% was obtained for Chit/TPP/Sm/Fe3O4/Rn with ratio 400:500:50:1:20. 
The relationship between the change in the intensity of flouresence and the release cumulative amount of 






























amount release of ranitidine, so that the changing of fluorescence intensity at wavelength of 590 nm referring to the 
Sm3+ ion could be used as indicator in DDS. The Sm3+ ions was bonded with the hydroxyl groups of chitosan that
resulted Sm3+ ions fluorescence intensity increases with the ranitidine cumulative amount released from the 
Chit/Sm/Fe3O4/Rn [5]. The existence of samarium in the chitosan matrix has function as a tracer or marker of drug 
release. The Sm3+ ions also contributes to improve the efficiency of drug loading (see Fig. 3(b)). The release profiles
of ranitidine showed that controlled release in sustained release with a diffusion mechanism with the release of up to 
40% on the 8th hour and perfectly separated at the 24th hour were observed.
. FIGURE 3. Fluorescence spectra of Chitosan-Fe-Ranitidine-Sm with various Sm concentrations (a), profiles of 
drug release from Chitosan-Fe-Sm-Ranitidine matrix (b)
CONCLUSION
In summary, a novel microsphere formulations of Chit/TPP/Sm/Fe3O4/Rn exhibit magnetic and fluorescent 
properties was developed. The ssustained release from microsphere formulation of Chit/TPP/Sm/Fe3O4/Rn with 
ratio 400:500:50:1:20, it allows to investigate the applications to other drugs. Furthermore, this is simple and
reproducible strategy to synthesize of microsphere formulation for various delivery carrier system.
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